Azathioprine for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38301
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2421
- Available Online
- View Pamphlet
Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Azathioprine
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2421
Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1465
- Available Online
- View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Cinacalcet
- Renal Insufficiency, Chronic - drug therapy
- Hyperparathyroidism, Secondary - drug therapy
- Subjects (LCSH)
- Chronic renal failure
- Hyperparathyroidism
- Kidneys--Diseases--Treatment
- Abstract
- Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
- Notes
- Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
- Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1465
Cyclophosphamide for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38303
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2422
- Available Online
- View Pamphlet
Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Cyclophosphamide
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2422
Cyclosporine for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38298
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2418
- Available Online
- View Pamphlet
Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Cyclosporine
- Glomerulonephritis
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2418
Dialysis patients : being prepared for an emergency
https://libcat.nshealth.ca/en/permalink/chpams35535
Nova Scotia Health Authority. Community Dialysis.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1564
- Available Online
- View Pamphlet
This pamphlet provides instructions on what dialysis patients should do if an emergency prevents them from starting or finishing their dialysis treatment at home or attending an appointment for dialysis. It explains what precautions to take, who to contact in an emergency, and what medications to take, and provides answers to common questions. The French version of this pamphlet 1901, "Patients recevant de la dialyse : se préparer en cas d’urgence", is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Community Dialysis
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - therapy
- Dialysis
- Subjects (LCSH)
- Kidneys--Diseases--Treatment
- Dialysis
- Abstract
- This pamphlet provides instructions on what dialysis patients should do if an emergency prevents them from starting or finishing their dialysis treatment at home or attending an appointment for dialysis. It explains what precautions to take, who to contact in an emergency, and what medications to take, and provides answers to common questions. The French version of this pamphlet 1901, "Patients recevant de la dialyse : se préparer en cas d’urgence", is also available.
- Responsibility
- Prepared by: Community Dialysis
- Pamphlet Number
- 1564
Lanthanum (Fosrenol) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1466
- Available Online
- View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Lanthanum
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
- Notes
- Previous title: Fosrenol (Lanthanum) and hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1466
Mycophenolate for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38300
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2420
- Available Online
- View Pamphlet
Mycophenolate mofetil or mycophenolic acid is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Mycophenolic Acid
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Mycophenolate mofetil or mycophenolic acid is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2420
One-Alpha® (alfacalcidol) and hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1470
- Available Online
- View Pamphlet
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can ca…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels of in the blood and weaker bones. One-Alpha® raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. One-Alpha® is a brand name for alfacalcidol.
- Responsibility
- Prepared by: Renal Pharmacy Team, Renal Program
- Pamphlet Number
- 1470
Patients recevant de la dialyse : se préparer en cas d’urgence
https://libcat.nshealth.ca/en/permalink/chpams36461
Nova Scotia Health Authority. Community Dialysis.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1901
- Available Online
- View Pamphlet
La présente brochure fournit des instructions sur ce que devraient faire les personnes dialysées si une urgence les empêche de commencer ou de terminer leur traitement de dialyse à la maison ou de se rendre à un rendez-vous de dialyse. Elle explique les précautions à prendre, indique avec qui communiquer en cas d’urgence et précise les médicaments à prendre. Elle répond aussi à des questions fréquemment posées. ; This pamphlet is a French translation of "Dialysis Patients: Being Prepared for an…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Community Dialysis
- Alternate Title
- Dialysis patients : being prepared for an emergency
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - therapy
- Dialysis
- Subjects (LCSH)
- Kidneys--Diseases--Treatment
- Dialysis
- Abstract
- La présente brochure fournit des instructions sur ce que devraient faire les personnes dialysées si une urgence les empêche de commencer ou de terminer leur traitement de dialyse à la maison ou de se rendre à un rendez-vous de dialyse. Elle explique les précautions à prendre, indique avec qui communiquer en cas d’urgence et précise les médicaments à prendre. Elle répond aussi à des questions fréquemment posées.
- This pamphlet is a French translation of "Dialysis Patients: Being Prepared for an Emergency" pamphlet 1564. This pamphlet provides instructions on what dialysis patients should do if an emergency prevents them from starting or finishing their dialysis treatment at home or attending an appointment for dialysis. It explains what precautions to take, who to contact in an emergency, and what medications to take, and provides answers to common questions.
- Responsibility
- Prepared by: Community Dialysis
- Pamphlet Number
- 1901
Prednisone for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38299
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2419
- Available Online
- View Pamphlet
Prednisone is a type of medication known as a corticosteroid. It works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Prednisone
- Glomerulonephritis
- Adrenal Cortex Hormones - therapeutic use
- Subjects (LCSH)
- Adrenocortical hormones
- Kidneys--Diseases--Treatment
- Abstract
- Prednisone is a type of medication known as a corticosteroid. It works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2419
Rituximab for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38304
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2423
- Available Online
- View Pamphlet
Rituximab is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and if this medication is safe during pregnancy and breastfeeding.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Rituximab
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Rituximab is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and if this medication is safe during pregnancy and breastfeeding.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2423
Rocaltrol® (calcitriol) and hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1468
- Available Online
- View Pamphlet
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amoun…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Calcitriol
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. Rocaltrol® is a brand name for calcitriol.
- Responsibility
- Prepared by: Renal Pharmacy Team, Renal Program
- Pamphlet Number
- 1468
Sevelamer (Renagel) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1464
- Available Online
- View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Sevelamer
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Abstract
- Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
- Notes
- Previous title: Renagel (Sevelamer) and Hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1464
Tacrolimus for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38305
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2424
- Available Online
- View Pamphlet
Tacrolimus is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Tacrolimus
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Tacrolimus is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2424
Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2307
- Available Online
- View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - drug therapy
- Subjects (LCSH)
- Kidneys--Diseases--Treatment
- Specialty
- Nephrology
- Medications
- Abstract
- Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2307
